Related Experiment Video
Updated: May 10, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders
Eino J H Palin1, Anders Paetau, Anu Suomalainen
1Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland. eino.palin@helsinki.fi
Abstract:
Genetic evidence from recessively inherited Parkinson's disease has indicated a clear causative role for mitochondrial dysfunction in Parkinson's disease. This role has long been discussed based on findings that toxic inhibition of mitochondrial respiratory complex I caused parkinsonism and that tissues of patients with Parkinson's disease show complex I deficiency. Disorders of mitochondrial DNA maintenance are a common cause of inherited neurodegenerative disorders, and lead to mitochondrial DNA deletions or depletion and respiratory chain defect, including complex I deficiency. However, parkinsonism associates typically with defects of catalytic domain of mitochondrial DNA polymerase gamma. Surprisingly, however, not all mutations affecting DNA polymerase gamma manifest as parkinsonism, but, for example, spacer region mutations lead to spinocerebellar ataxia and/or severe epilepsy. Furthermore, defective Twinkle helicase, a close functional companion of DNA polymerase gamma in mitochondrial DNA replication, results in infantile-onset spinocerebellar ataxia, epilepsy or adult-onset mitochondrial myopathy, but not typically parkinsonism. Here we sought for clues for this specificity in the neurological manifestations of mitochondrial DNA maintenance disorders by studying mesencephalic neuropathology of patients with DNA polymerase gamma or Twinkle defects, with or without parkinsonism. We show here that all patients with mitochondrial DNA maintenance disorders had neuronopathy in substantia nigra, most severe in DNA polymerase gamma-associated parkinsonism. The oculomotor nucleus was also affected, but less severely. In substantia nigra, all patients had a considerable decrease of respiratory chain complex I, but other respiratory chain enzymes were not affected. Complex I deficiency did not correlate with parkinsonism, age, affected gene or inheritance. We conclude that the cell number in substantia nigra correlated well with parkinsonism in DNA polymerase gamma and Twinkle defects. However, complex I defect is a general consequence of mitochondrial DNA maintenance defects, and does not explain manifestation of parkinsonism or degree of mesencephalic cell death in patients with mitochondrial DNA maintenance disorders.
Insights
Mitochondrial DNA maintenance disorders cause neuron damage in the substantia nigra, but complex I deficiency doesn't explain Parkinson's disease. Neuron loss in the substantia nigra correlates with Parkinson's symptoms in these genetic disorders.
Area of Science:
- Neuroscience
- Genetics
- Mitochondrial Biology
Background:
- Recessive Parkinson's disease genetics implicate mitochondrial dysfunction.
- Mitochondrial DNA maintenance disorders can cause neurodegeneration and respiratory chain defects.
- Parkinsonism is linked to mitochondrial DNA polymerase gamma defects, but not all mutations cause it.
Purpose of the Study:
- Investigate the specificity of neurological manifestations in mitochondrial DNA maintenance disorders.
- Examine mesencephalic neuropathology in patients with DNA polymerase gamma or Twinkle defects.
- Determine the role of complex I deficiency in parkinsonism associated with these disorders.
Main Methods:
- Studied mesencephalic neuropathology in patients with mitochondrial DNA maintenance disorders.
- Analyzed substantia nigra and oculomotor nucleus in patients with DNA polymerase gamma or Twinkle defects.
- Assessed respiratory chain enzyme activity, particularly complex I.
Main Results:
- All patients showed neuronopathy in the substantia nigra, most severe in DNA polymerase gamma-associated parkinsonism.
- Substantia nigra exhibited decreased respiratory chain complex I in all patients, irrespective of parkinsonism.
- Neuron count in the substantia nigra correlated with parkinsonism severity, not complex I deficiency.
Conclusions:
- Complex I deficiency is a general consequence of mitochondrial DNA maintenance defects.
- Substantia nigra neuron loss, not complex I defect, correlates with parkinsonism in these disorders.
- The specific neurological outcome depends on factors beyond general mitochondrial dysfunction.
Related Concept Videos
Animal Mitochondrial Genetics
Parkinson Disease ll: Pathophysiology
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
